J&J builds case for Talvey; FDA panel questions PD-1 drugs for certain cancers
New data show Talvey’s potential in multiple myeloma drug combinations. Elsewhere, AbbVie got more positive Parkinson’s drug ...
New schizophrenia drug could ‘change the lives of millions of people’
The US Food and Drug Administration has approved the new drug Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.
WBAL4m
FDA approves first new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...
abp LIVE15m
Allahabad HC Summons Food Safety Official Over Chinese Garlic: Why Is It Dangerous & How To Identify?
Chinese garlic was banned amid reports of fungus-infested garlic entering India. Concerns have also been raised about the ...
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...
verywellhealth24m
Why You May Need an Ultrasound Test and What to Expect
An ultrasound gives providers a better view of internal organs. They’re used to help diagnose conditions and monitor ...
You're Probably Eating Way Too Much Salt. Here's How to Tell.
Americans are eating too much salt. According to the FDA, Americans eat on average about 3,400 mg of sodium per day—more than ...
sanofi31m
Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
Dupixent approved in the US as the first-ever biologic medicine for patients with COPD         Dupixent is indicated for the approximately 300,000 adults in the US with inadequately ...
verywellhealth33m
FDA Clears the First Implantable Continuous Glucose Monitor That Can Last a Year
The FDA has cleared the implantable Eversense 365 CGM, which can last up to a year without replacement. The device requires ...
Pharmaceutical Technology35m
Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials
The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.
Medscape38m
FDA OKs First-in-Class Antipsychotic for Schizophrenia
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.